Mnemosyne Pharmaceuticals, Inc.: Series A $5.4M

Posted in I - Series A, Q - 1Q12, R - NORTH EAST, X - Alzheimer's, X - Schizophrenia, XX - RI

Mnemosyne Pharmaceuticals (Providence, RI) a development-stage small molecule company focused on neuropsychiatric disorders such as schizophrenia and Alzheimer’s, closed a $5.4M Series financing Participants include Access BridgeGap Ventures and Slater Technology Fund. Note: Closing out 1Q deals. Thanx for your patience as we play catch-up.

Mar

2012

Collegium Pharmaceutical, Inc.: Series B $22.5M

Posted in I - Series B, Q - 1Q12, R - NORTH EAST, X - Pain, XX - RI

Collegium Pharmaceutical (Cumberland, RI) a clinical-stage small molecule company focused on the development of innovative treatments for chronic pain, closed a $22.5M Series B financing. Participants include Longitude Capital, Skyline Ventures, Frazier Healthcare Ventures and Boston Millennia Partners.

Jan

2012

NABsys, Inc.: Series C $10M

Posted in I - Series C, Q - 3Q11, R - NORTH EAST, X - Device (Sequencing), XX - RI

NABsys (Providence, RI) a development stage dna sequencing company focused on nanopore arrays that can do not require amplification or labeling, closed a $10M Series C financing. Participants include Stata Venture. Thanx for your patience as we catch-up.

Dec

2010

Beech Tree Labs, Inc.: Series B $7M

Posted in I - Series B, Q - 4Q10, R - NORTH EAST, X - Antiviral, X - HSV, X - Influenza, XX - RI

Beech Tree Labs (Providence, RI) a clinical-stage antiviral company focused on influenza and herpes, closed a $7M Series B financing. Participants were not identified.

Mar

2010

NABsys, Inc.: Series B $7M

Posted in I - Series B, Q - 1Q10, R - NORTH EAST, X - Device (Sequencing), XX - RI

NABsys (Providence, RI) a development-stage company focused on polymerase-free solid-state electronic detection DNA sequencing free of amplification or labeling focused point-of-care clinical use, closed a $7M Series B financing. Participants include Stata Venture Partners and Point Judith Capital. _________________________________________________________________________ NOTE: New OnBioVC Friday feature coming, well…this Friday!

to top of page...